Is Bambusa Therapeutics Inc. overvalued?

Bambusa Therapeutics Inc. (BBTX) — key valuation metrics and fundamentals.

No verdict

Price

$16.09

Fair value

—

Current P/E

—

Normal P/E

—

Market cap

$800.7M

Dividend yield

0.0%

Return on equity

—

Sector

Healthcare

Fair value compares BBTX's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.

Related stocks